255 related articles for article (PubMed ID: 9246051)
1. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine-induced cholestatic liver disease.
Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
[TBL] [Abstract][Full Text] [Related]
3. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction?
Geubel AP; Nakad A; Rahier J; Dive C
Liver; 1988 Dec; 8(6):350-3. PubMed ID: 3265170
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine hepatotoxicity: case report and review of the literature.
Fernandes NF; Geller SA; Fong TL
Am J Gastroenterol; 1998 Mar; 93(3):459-60. PubMed ID: 9517658
[TBL] [Abstract][Full Text] [Related]
5. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
Kumar K; Gill A; Shafei R; Wright JL
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine-associated hepatic injury.
van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis attributed to the use of terbinafine].
Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
[TBL] [Abstract][Full Text] [Related]
8. Terbinafine-induced hepatic dysfunction.
Chambers WM; Millar A; Jain S; Burroughs AK
Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
[TBL] [Abstract][Full Text] [Related]
9. Terbinafine hepatotoxicity. A case report and review of literature.
Zapata Garrido AJ; Romo AC; Padilla FB
Ann Hepatol; 2003; 2(1):47-51. PubMed ID: 15094707
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine-induced hepatotoxicity.
Mejías Manzano MLÁ; Giráldez Gallego Á; Ontanilla Clavijo G; Sousa Martín JM
Gastroenterol Hepatol; 2019; 42(6):394-395. PubMed ID: 31167724
[No Abstract] [Full Text] [Related]
11. [Acute hepatitis associated with terbinafine].
Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
Agca E; Akcay A; Simsek H
Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
[No Abstract] [Full Text] [Related]
13. [Terbinafine-induced cholestatic liver injury].
Shiloah E; Horowiz M; Zecler E
Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
[TBL] [Abstract][Full Text] [Related]
14. [Terbinafine and cholestatic hepatitis].
Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
[No Abstract] [Full Text] [Related]
15. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
Ley D; Musto J; Said A
WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
[TBL] [Abstract][Full Text] [Related]
16. Reversible cholestasis with bile duct injury following azathioprine therapy. A case report.
Horsmans Y; Rahier J; Geubel AP
Liver; 1991 Apr; 11(2):89-93. PubMed ID: 2051906
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine-associated hepatotoxicity.
Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
[TBL] [Abstract][Full Text] [Related]
18. Prolonged cholestasis after troleandomycin-induced acute hepatitis.
Larrey D; Amouyal G; Danan G; Degott C; Pessayre D; Benhamou JP
J Hepatol; 1987 Jun; 4(3):327-9. PubMed ID: 3496378
[TBL] [Abstract][Full Text] [Related]
19. [Terbinafine induced hepatitis with persistent cholestasis].
Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
[No Abstract] [Full Text] [Related]
20. Terbinafine-induced hepatic failure requiring liver transplantation.
Perveze Z; Johnson MW; Rubin RA; Sellers M; Zayas C; Jones JL; Cross R; Thomas K; Butler B; Shrestha R
Liver Transpl; 2007 Jan; 13(1):162-4. PubMed ID: 17192859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
